FDA approves first drug for the 'Jolie gene' (0)

English Daily Mail 1 week ago 2
The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with BRCA gene mutations who have undergone chemotherapy.
Read The Rest at Daily Mail Back to news

NB! Comments are published by the readers.
Accept rules.

Comments (0)

Please Insert Your Name Please Write Your Comment Error Happened